NPs Basic Information

Name
Asperergoster A
Molecular Formula C28H40O4
IUPAC Name*
(9R,10R,12R,13R,15S,17R)-12,15-dihydroxy-17-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-1,2,9,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one
SMILES
C[C@H](/C=C/[C@H](C)C(C)(C)O)[C@H]1C[C@@H](C2=C3C=CC4=CC(=O)CC[C@@]4([C@H]3C[C@H]([C@]12C)O)C)O
InChI
InChI=1S/C28H40O4/c1-16(7-8-17(2)26(3,4)32)21-14-23(30)25-20-10-9-18-13-19(29)11-12-27(18,5)22(20)15-24(31)28(21,25)6/h7-10,13,16-17,21-24,30-32H,11-12,14-15H2,1-6H3/b8-7+/t16-,17+,21-,22+,23+,24-,27+,28+/m1/s1
InChIKey
RDZXYBLXIRJYJG-LSJGDYQFSA-N
Synonyms
Asperergoster A
CAS NA
PubChem CID 156582410
ChEMBL ID NA
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Lipids and lipid-like mol
      • Class: Steroids and steroid deri
        • Subclass: Ergostane steroids
          • Direct Parent: Ergosterols and derivativ

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 440.6 ALogp: 2.8
HBD: 3 HBA: 4
Rotatable Bonds: 4 Lipinski's rule of five: Accepted
Polar Surface Area: 77.8 Aromatic Rings: 4
Heavy Atoms: 32 QED Weighted: 0.537

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.927 MDCK Permeability: 0.00002000
Pgp-inhibitor: 0.999 Pgp-substrate: 0.959
Human Intestinal Absorption (HIA): 0.617 20% Bioavailability (F20%): 0.942
30% Bioavailability (F30%): 0.845

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.275 Plasma Protein Binding (PPB): 87.69%
Volume Distribution (VD): 1.204 Fu: 2.35%

ADMET: Metabolism

CYP1A2-inhibitor: 0.018 CYP1A2-substrate: 0.107
CYP2C19-inhibitor: 0.028 CYP2C19-substrate: 0.813
CYP2C9-inhibitor: 0.101 CYP2C9-substrate: 0.153
CYP2D6-inhibitor: 0.006 CYP2D6-substrate: 0.118
CYP3A4-inhibitor: 0.55 CYP3A4-substrate: 0.736

ADMET: Excretion

Clearance (CL): 1.706 Half-life (T1/2): 0.752

ADMET: Toxicity

hERG Blockers: 0.533 Human Hepatotoxicity (H-HT): 0.419
Drug-inuced Liver Injury (DILI): 0.158 AMES Toxicity: 0.026
Rat Oral Acute Toxicity: 0.961 Maximum Recommended Daily Dose: 0.998
Skin Sensitization: 0.911 Carcinogencity: 0.044
Eye Corrosion: 0.003 Eye Irritation: 0.014
Respiratory Toxicity: 0.965
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC004999 0.842 D0N1TP 0.388
ENC004997 0.794 D0G5CF 0.302
ENC003739 0.631 D0F1UL 0.293
ENC004998 0.541 D05BTM 0.273
ENC003880 0.514 D0T2PL 0.273
ENC004737 0.495 D01QUS 0.271
ENC004022 0.495 D0G8OC 0.267
ENC001861 0.495 D04SFH 0.262
ENC003368 0.482 D06XMU 0.261
ENC004834 0.474 D06JPB 0.258
*Note: the compound similarity was calculated by RDKIT.